Janney Montgomery Scott’s Juno Therapeutics, Inc. JUNO Stock Holding History

Janney Montgomery Scott’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,665	Closed	-$213K	–	2056
2017 Q4	$213K	Buy	+4,665	New	+$233K	﹤0.01%	1768

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Janney Montgomery Scott's JUNO Position: Q1 2018 in Review

Janney Montgomery Scott sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 4,665 shares — an estimated $213K sold.

Janney Montgomery Scott first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $213K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Janney Montgomery Scott reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Janney Montgomery Scott sold 4,665 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $213K.
Janney Montgomery Scott first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Janney Montgomery Scott's Juno Therapeutics, Inc. position peaked at $213K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Janney Montgomery Scott's 13F filing for Q1 2018, filed 19 Apr 2018.